GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Wiley ; 2023
    In:  JDDG: Journal der Deutschen Dermatologischen Gesellschaft Vol. 21, No. 5 ( 2023-05), p. 555-564
    In: JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Wiley, Vol. 21, No. 5 ( 2023-05), p. 555-564
    Abstract: Superfizielle Leiomyosarkome (LMS) sind seltene Tumoren (circa 2–3% aller kutanen Sarkome), die von dermal gelegenen Haarbalgmuskeln, Dartosmuskeln beziehungsweise areolären Muskeln (dermale LMS) oder der Muskulatur der Gefäße des subkutanen Fettgewebes (subkutane LMS) ausgehen. Diese superfiziellen LMS werden von den LMS der tiefen Weichgewebe abgegrenzt. Leiomyosarkome sind typischerweise an den unteren Extremitäten, am Rumpf oder am Kapillitium lokalisiert und präsentieren sich als schmerzhafte, erythematös bis bräunliche Tumorknoten. Die Diagnosestellung erfolgt histopathologisch. Die Therapie der Wahl ist die vollständige mikroskopisch kontrollierte Exzision des Primärtumors mit einem Sicherheitsabstand von mindestens 1 cm bei dermalen LMS, und möglichst 2 cm bei subkutanen LMS. Nichtoperable oder metastasierte LMS erfordern eine individuelle Therapieentscheidung. Nach R0‐Resektion mittels mikroskopisch kontrollierter Chirurgie und einem Mindestsicherheitsabstand von 1 cm ist das Lokalrezidivrisiko für dermale LMS sehr gering und eine Metastasierung sehr selten. Subkutane LMS, sehr große, oder unvollständig resezierte LMS rezidivieren und metastasieren häufiger. Aus diesem Grund erscheinen für die Nachsorge der dermalen LMS initial klinische Untersuchungen halbjährlich, bei subkutanen LMS alle 3 Monate, später jährlich und entsprechend halbjährlich für mindestens 5 Jahre empfehlenswert (bei subkutanen LMS inklusive Sonographie der lokoregionären Lymphknoten). Apparative Untersuchungen wie Schnittbildgebung erscheinen lediglich bei Primärtumoren mit Besonderheiten, Rezidiven oder bereits metastasierten Tumoren indiziert.
    Type of Medium: Online Resource
    ISSN: 1610-0379 , 1610-0387
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2099463-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    S. Karger AG ; 2021
    In:  International Archives of Allergy and Immunology Vol. 182, No. 9 ( 2021), p. 819-826
    In: International Archives of Allergy and Immunology, S. Karger AG, Vol. 182, No. 9 ( 2021), p. 819-826
    Abstract: 〈 b 〉 〈 i 〉 Background: 〈 /i 〉 〈 /b 〉 Hereditary angioedema (HAE) is associated with relevant disease-related burden. We aimed at investigating prevalence of depression and anxiety in patients with HAE in Leipzig, Germany. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 Questionnaire-based evaluation of medical history, Angioedema Control Test (AECT), Angioedema Quality of Life Questionnaire (AE-QoL), Generalized Anxiety Disorder Scale-7 (GAD-7), and Hospital Anxiety and Depression Scale (HADS). 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Thirty-seven patients with HAE were included (31 females, mean age 49.6 ± 17.5 years). A mean diagnostic delay between first symptoms and correct diagnosis of 14.2 ± 14.5 years was detected. Patients aged & #x3c;50 years ( 〈 i 〉 n 〈 /i 〉 = 18) had been diagnosed significantly earlier with HAE than older patients ( 〈 i 〉 p 〈 /i 〉 = & #x3c;0.001). In 6 patients (16.2%), unnecessary medical interventions were performed and 14 patients (43.8%) reported at least 1 HAE-related death of a family member. Psychological stress was the most common triggering factor (96.2%). HADS scores revealed depression in 5/37 patients (13.5%) and anxiety in 16/37 (43.2%), GAD-7 score indicated anxiety in 9/36 (25%) participants. Patients receiving long-term prophylactic treatment ( 〈 i 〉 n 〈 /i 〉 = 17, 45.9%) showed significantly better disease control (AECT; 〈 i 〉 p 〈 /i 〉 = & #x3c;0.001) and quality of life (AE-QoL; 〈 i 〉 p 〈 /i 〉 = & #x3c;0.001) compared to those with on-demand treatment only. Patients with long-term prophylactic treatment showed significantly lower scores for anxiety and depression at GAD-7 ( 〈 i 〉 p 〈 /i 〉 = 0.011) and HADS (anxiety: 〈 i 〉 p 〈 /i 〉 = 0.021; depression: 〈 i 〉 p 〈 /i 〉 = 0.008). In 5 patients, treatment regime was changed as AECT score indicated insufficient disease control. Subsequently, we measured significant improvement of quality of life (AE-QoL, 〈 i 〉 p 〈 /i 〉 = 0.04) and disease control (AECT; 〈 i 〉 p 〈 /i 〉 = 0.032). 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 Anxiety was a frequent burden in our study group and showed a significant association with low disease control. Our data indicate that prophylactic HAE treatment can improve psychosocial burden of HAE.
    Type of Medium: Online Resource
    ISSN: 1018-2438 , 1423-0097
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2021
    detail.hit.zdb_id: 1482722-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Dustri-Verlgag Dr. Karl Feistle ; 2020
    In:  Allergologie select Vol. 4, No. 01 ( 2020-01-01), p. 86-96
    In: Allergologie select, Dustri-Verlgag Dr. Karl Feistle, Vol. 4, No. 01 ( 2020-01-01), p. 86-96
    Type of Medium: Online Resource
    ISSN: 2512-8957
    Language: English
    Publisher: Dustri-Verlgag Dr. Karl Feistle
    Publication Date: 2020
    detail.hit.zdb_id: 2893503-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    S. Karger AG ; 2022
    In:  International Archives of Allergy and Immunology Vol. 183, No. 4 ( 2022), p. 409-414
    In: International Archives of Allergy and Immunology, S. Karger AG, Vol. 183, No. 4 ( 2022), p. 409-414
    Abstract: 〈 b 〉 〈 i 〉 Background: 〈 /i 〉 〈 /b 〉 Atopic eczema (AE) is known to be associated with depression and anxiety. We aimed at investigating the occurrence of selected psychological comorbidities in patients with AE under treatment in our university dermatological department. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 Monocentric prospective examination of adult AE patients using PO-SCORAD (Patient-Oriented Severity Scoring of AD), EASI (Eczema Area and Severity Index), POEM (Patient-Oriented Eczema Measure), DLQI (Dermatologic Life Quality Index), LSNS-6 (Lubben Social Network Scale 6), CES-D (Center for Epidemiologic Studies Depression Scale), HADS-D and -A (Hospital Anxiety and Depression Scale), and GAD-7 (Generalized Anxiety Disorder Scale-7) was carried out. We looked for correlations between AE severity and psychosocial comorbidities. Data were compared with age- and sex-matched controls from nonatopic subjects. Statistics: Mann-Whitney U test and Spearman’s rank correlation were used. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Eighty-four patients (44 women, median age 35.0 years, range: 19.4–92.8 years) were included. PO-SCORAD was 40.4 [23.4–55.4] (median [interquartile range] ), EASI 9.3 [3.4–18.9], POEM 16 [8–24] , and DLQI 10 [4–18]. Compared with 161 from the healthy LIFE-Adult cohort controls, our patients with AE had significantly higher scores for HADS, GAD-7, and CES-D ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.001, respectively), but there was no increase in the LSNS score (18 vs. 19; 〈 i 〉 p 〈 /i 〉 = 0.067). Within the group of AE patients, there was a significant correlation of the subjective skin severity and the depression and anxiety values: POEM significantly correlated with GAD-7, CES-D, and HADS-A and -D ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.001). PO-SCORAD significantly correlated with GAD-7 and CES-D ( 〈 i 〉 p 〈 /i 〉 & #x3c; 0.05). EASI correlated neither with HADS-A or -D nor with CES-D. Patients with suicidal thoughts, plans, or attempts in the last 12 months had significantly more severe AE than those without (POEM 25 [15.3–26] vs. 15 [7–23] ; 〈 i 〉 p 〈 /i 〉 = 0.013, and PO-SCORAD 51.6 [40.2–63] vs. 20.5 [20.7–52] ; 〈 i 〉 p 〈 /i 〉 = 0.014). 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 Patients with AE being currently under treatment in our department had significantly increased scores indicating depression and anxiety. Suicidal tendency was increased in patients with severe AE. 〈 b 〉 〈 i 〉 Key Message: 〈 /i 〉 〈 /b 〉 AE patients may develop depression, anxiety, and suicidal ideation. Patient-oriented scores may help identifying high-risk patients.
    Type of Medium: Online Resource
    ISSN: 1018-2438 , 1423-0097
    RVK:
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2022
    detail.hit.zdb_id: 1482722-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Wiley ; 2021
    In:  The Journal of Dermatology Vol. 48, No. 10 ( 2021-10)
    In: The Journal of Dermatology, Wiley, Vol. 48, No. 10 ( 2021-10)
    Type of Medium: Online Resource
    ISSN: 0385-2407 , 1346-8138
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2222121-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Wiley ; 2020
    In:  JDDG: Journal der Deutschen Dermatologischen Gesellschaft Vol. 18, No. 2 ( 2020-02), p. 93-102
    In: JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Wiley, Vol. 18, No. 2 ( 2020-02), p. 93-102
    Abstract: Atopic dermatitis (AD) is a chronic inflammatory disease that may be associated with a number of comorbidities including psychosocial disorders, which are the primary focus of this article. The data presented is based on a literature search in PubMed and subsequent screening of relevant review articles and guidelines. There is a greater prevalence of depression, anxiety, sleep disorders and suicidal ideation among individuals with AD. The disease negatively impacts patients’ quality of life. Children with AD have been shown to more commonly exhibit signs of attention‐deficit/hyperactivity disorder. Only little data exists on the association of AD with schizophrenia, eating disorders or obsessive‐compulsive disorder. There is a great need for research in the field of AD‐related comorbidities, especially with respect to the question as to whether and how novel treatment options may potentially affect these comorbidities.
    Type of Medium: Online Resource
    ISSN: 1610-0379 , 1610-0387
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2099463-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Wiley ; 2020
    In:  JDDG: Journal der Deutschen Dermatologischen Gesellschaft Vol. 18, No. 2 ( 2020-02), p. 93-102
    In: JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Wiley, Vol. 18, No. 2 ( 2020-02), p. 93-102
    Abstract: Die atopische Dermatitis (AD) ist eine chronisch‐entzündliche Erkrankung, die mit einer Reihe von Komorbidität assoziiert sein kann, hierzu zählen auch psychosoziale Erkrankungen, zu denen hier eine Übersicht gegeben werden soll. Hierzu erfolgten eine Literaturrecherche in PubMed sowie gezieltes Screening von Übersichtsarbeiten und Leitlinien. Bei Patienten mit AD wird ein gehäuftes Auftreten von Depression, Angststörung, Schlafstörung und Suizidalität berichtet. Die Erkrankung hat negative Effekte auf die Lebensqualität. Bei Kindern wurde vermehrt das gemeinsame Auftreten der AD mit der Aufmerksamkeitsdefizit‐/Hyperaktivitätsstörung nachgewiesen. Weniger gut untersucht ist der Zusammenhang zwischen AD und Erkrankungen wie Schizophrenie, Essstörung und Zwangsstörung. Bezüglich der Komorbidität bei der AD gibt es hohen Forschungsbedarf, gerade auch im Hinblick darauf, ob und wie neuere Therapien diese Komorbidität beeinflussen.
    Type of Medium: Online Resource
    ISSN: 1610-0379 , 1610-0387
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2099463-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Elsevier BV ; 2022
    In:  Annals of Allergy, Asthma & Immunology Vol. 128, No. 2 ( 2022-02), p. 218-220
    In: Annals of Allergy, Asthma & Immunology, Elsevier BV, Vol. 128, No. 2 ( 2022-02), p. 218-220
    Type of Medium: Online Resource
    ISSN: 1081-1206
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    Knowledge E DMCC ; 2023
    In:  Iranian Journal of Allergy, Asthma and Immunology ( 2023-01-01)
    In: Iranian Journal of Allergy, Asthma and Immunology, Knowledge E DMCC, ( 2023-01-01)
    Abstract: The green-lipped mussel (Perna canaliculus) originates from New Zealand. To preserve the health benefits of green-lipped mussel meat, it is freeze-dried to make a long-lasting powder. The powder is used to treat arthritis because of its potential anti-inflammatory properties. The report describes a 54-year-old woman who developed immediate rhinoconjunctival and respiratory symptoms after inhaling green-lipped mussel powder she gave to her dog for arthritis. A skin prick test with green-lipped mussel powder was performed. Protein extracts from P canaliculus were separated by sodium dodecyl–sulfate polyacrylamide (SDS) gel electrophoresis and probed with serum from patients and serum preincubated with green-lipped mussel extract. Bound immunoglobulin E (IgE) was detected by specific anti-human-IgE antibodies, and IgE-binding proteins were subsequently identified by liquid chromatography and mass spectrometry. The skin prick test was positive for green-lipped mussel. Specific IgE against green-lipped mussel extract was detected using Western immunoblotting. These potential allergenic proteins were identified by mass spectrometry as actin, tropomyosin, and paramyosin. All three allergens are reported for the first time for P canaliculus. Actin is a major allergen in Paphia textile, paramyosin in Sarcoptes scarbiei, and tropomyosin in Haliotis discus. For all IgE-binding proteins, the software AllCatPro predicted high allergenicity, supporting our conclusion that these proteins from P canaliculus may also be allergenic. The identification of allergens from P canaliculus provides the opportunity for specific tests to assess the frequency of allergic reactions to P canaliculus.
    Type of Medium: Online Resource
    ISSN: 1735-5249 , 1735-1502
    Language: Unknown
    Publisher: Knowledge E DMCC
    Publication Date: 2023
    detail.hit.zdb_id: 2388260-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    Wiley ; 2023
    In:  JDDG: Journal der Deutschen Dermatologischen Gesellschaft Vol. 21, No. 5 ( 2023-05), p. 555-563
    In: JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Wiley, Vol. 21, No. 5 ( 2023-05), p. 555-563
    Abstract: Superficial leiomyosarcomas (LMS) are rare skin cancers (2–3% of cutaneous sarcomas) that originate from dermally located hair follicle muscles, dartos or areolar muscles (cutaneous/dermal LMS), or from vascular muscle cells of the subcutaneous adipose tissue (subcutaneous LMS). These superficial LMS are distinct from LMS of the deep soft tissues. Leiomyosarcomas are typically localized at the lower extremities, trunk or capillitium, and present as painful, erythematous to brownish nodules. Diagnosis is made by histopathology. The treatment of choice for primary LMS is complete (R0) microscopically controlled excision, with safety margins of 1 cm in dermal LMS, and 2 cm in subcutaneous LMS, if possible. Non‐resectable or metastatic LMS require individual treatment decisions. After R0 resection with 1 cm safety margins, the local recurrence rate of dermal LMS is very low, and metastasis is very rare. Subcutaneous LMS, very large, or incompletely excised LMS recur and metastasize more frequently. For this reason, clinical follow‐up examinations are recommended every six months for cutaneous LMS, and every three months for subcutaneous LMS within the first two years (in subcutaneous LMS including locoregional lymph node sonography). Imaging such as CT/MRI is indicated only in primary tumors with special features, recurrences, or already metastasized tumors.
    Type of Medium: Online Resource
    ISSN: 1610-0379 , 1610-0387
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2099463-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...